This volume investigates the evolving biochemical mechanisms of depression and the subsequent development of novel pharmacological treatment approaches. Authors Stuart A. Montgomery and Timothy H. Corn, both established experts in psychopharmacology, synthesize clinical research and receptor subtype analysis to challenge traditional understandings of depressive disorders. They argue that the complexity of the condition necessitates a shift toward more nuanced, mechanism-based therapeutic interventions.

Experts recognize this monograph as a specialized technical resource for researchers and clinicians focusing on the neurobiology of mood disorders. Readers frequently note the high level of academic density and the specific focus on biochemical mechanisms rather than general clinical management.